Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Objective: To review published algorithms for guiding the use of methylphenidate (MPH) in the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. Methods: A consensus roundtable of 12 experts was convened to review the evidence for the safety and efficacy of MPH in the treatment of ADHD, as well as the published algorithms and practice guidelines for using MPH. The experts reviewed the algorithms for practicality and acceptability by clinicians. Results: Algorithms that included MPH commonly selected it as the initial medication to be employed in the treatment of children with ADHD. Factors involved included its high efficacy, good safety record, and the ubiquitous nature of its appearance in the ADHD treatment literature. Conclusions: MPH should be considered as the first medication to be used in a treatment algorithm for children and adolescents with ADHD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“stimulant medication, a well-studied and empirically supported treatment for ADHD (Greenhill et al., 2002; Plizska 2007).”
From Improving Working Memory in Children with Attention-Deficit/Hyperactivity Disorder: The Separate and Combined Effects of Incentives and Stimulant Medication (2012) · cites this paper as Greenhill et al., 2002
Citations
Cites
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations
Grimshaw, J. M., & Russell, I. T. (1993) · The Lancet · doi:10.1016/0140-6736(93)92244-n · Cited by 2,770
Conners' rating scales-revised : technical manual
Conners, C. K. (1997) · Medical Entomology and Zoology · Cited by 1,368
Self-citationMannuzza, S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820190067007 · Cited by 1,368
SWANSON, J. M., KRAEMER, H. C., HINSHAW, S. P., ARNOLD, L. E., CONNERS, C. K., ABIKOFF, H. B., CLEVENGER, W., DAVIES, M., ELLIOTT, G. R., GREENHILL, L. L., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00011 · Cited by 1,157
Self-citationGender Differences in ADHD: A Meta-Analysis and Critical Review
GAUB, M., & CARLSON, C. L. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199708000-00011 · Cited by 1,117
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman, L. S. (1998) · JAMA · doi:10.1001/jama.279.14.1100 · Cited by 1,082
Committee on Quality Improvement, S. O. A.-D. D. (2000) · Pediatrics · doi:10.1542/peds.105.5.1158 · Cited by 1,076
Ontario Child Health Study: II. Six-Month Prevalence of Disorder and Rates of Service Utilization
Offord, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800210084013 · Cited by 1,041
Cohen, P., Cohen, J., Kasen, S., Velez, C. N., Hartmark, C., Johnson, J., Rojas, M., Brook, J., & Streuning, E. L. (1993) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1993.tb01094.x · Cited by 957
Research works printed but not linked: 9
- 2002, 2002 Drug Topics Red Book
- American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders, 4th Editition (DSM-IV).
- Columbia University Treatment Guidelines, 2002, ADHD.
- Guy W., 1976, ECDEU assessment manual for psychopharmacology—Revised.
- Jobson K. O., 1995, Psychopharmacology Bulletin, 31, 457
- Swanson J., 1992, School-based assessments and interventions for ADD students.
- Swanson J., 1998, Psychopharmacology Bulletin, 34, 55
- Weiss G., 1993, Hyperactive children grown up. 2nd ed.
- World Health Organization, 1993, The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for research.
Cited by
Faraone, S. V., Spencer, T., Aleardi, M., Pagano, C., & Biederman, J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000108984.11879.95 · Cited by 404
Self-citationGraham, J., & Coghill, D. (2008) · CNS Drugs · doi:10.2165/00023210-200822030-00003 · Cited by 185
“According to the AACAP guidelines,[87] stimulants may either worsen or improve irritable mood”
MethodDopaminergic and Noradrenergic Contributions to Functionality in ADHD: The Role of Methylphenidate
Engert, V., & Pruessner, J. (2008) · Current Neuropharmacology · doi:10.2174/157015908787386069 · Cited by 146
“In ADHD patients, MPH reduces symptoms of impulsiveness, overactivity and inattention in up to 70% of affected children [23, 49].”
BackgroundDoyle, C. A., & McDougle, C. J. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.3/cdoyle · Cited by 136
Bizarro, L., Patel, S., Murtagh, C., & Stolerman, I. P. (2004) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000131574.61491.50 · Cited by 113
“Anticipatory responding in the 5-CSRTT is usually interpreted as a measure of impulsivity (Robbins, 2002) and in this sense the profile of effects of methylphenidate in the present version of the 5-CSRTT may reflect its therapeutic efficacy in ADHD, for which it is one of the most preferred treatments (Garland, 1998;…”
Background
Metadata
- Authors
- Greenhill, L., Beyer, D. H., Finkleson, J., Shaffer, D., Biederman, J., Conners, C. K., Gillberg, C., Huss, M., Jensen, P., Kennedy, J. L., Klein, R., Rapoport, J., Sagvolden, T., Spencer, T., Swanson, J. M., & Volkow, N.
- Affiliations
- New York State Psychiatric Institute (US)
- Novartis Pharmaceuticals.
- Harvard University (US)
- Duke Medical Center (US)
- St George's, University of London (GB)
- Humboldt-Universität zu Berlin (DE)
- Centre for Addiction and Mental Health (CA)
- New York University (US)
- University of Oslo (NO)
- University of California, Irvine (US)
- Brookhaven National Laboratory (US)
- ORCID
- Venue
- Journal of Attention Disorders
- Publisher
- SAGE Publications
- Published
- 2002-04
- Volume
- 6
- Issue
- 1_suppl
- Pages
- 89-100
- ISSN
- 1087-0547 (ISSN-L)
- 1557-1246
- OpenAlex
- W71528383
- Cited by
- 80
- References
- 33
- Citations by year
- 2026: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2018: 5 · 2017: 4 · 2016: 9 · 2015: 3 · 2014: 1 · 2013: 1 · 2012: 9
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Attention Disorders (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute for Health and Care Research
- National Institutes of Health
- National Institute of Mental Health (1MH60005)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Keywords
- methylphenidate, attention deficit hyperactivity disorder, children, adolescents, treatment algorithm, drug selection, first-line pharmacotherapy, drug safety, drug efficacy, expert consensus
- MeSH terms
- Adolescent, Algorithms, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Consensus Statements as Topic, Humans, Methylphenidate, Treatment Outcome, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder. https://app.cochat.ai/papers/10.1177/070674370200601s11
- The paper
- Greenhill, L., Beyer, D. H., Finkleson, J., Shaffer, D., Biederman, J., Conners, C. K., Gillberg, C., Huss, M., Jensen, P., Kennedy, J. L., Klein, R., Rapoport, J., Sagvolden, T., Spencer, T., Swanson, J. M., & Volkow, N. (2002). Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder. Journal of Attention Disorders. https://doi.org/10.1177/070674370200601s11
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.